CMS Doubles Up On Test Reimbursements, Will Pay Labs $100 Per Test For COVID-19 Clinical Diagnostic Assays
Compensation nearly double the current $51-per-test rate
The US Medicare agency said on 15 April it will double its reimbursement rate for certain COVID-19 lab tests.
You may also be interested in...
Participants in CMS's Quality Payment Program can earn credit to boost their Medicare reimbursements by reporting information from COVID-19 drug trials through a clinical trial repository or registry; NIH issues treatment guidelines for the coronavirus that are to be continuously updated.
A $5bn emergency fund reimbursing US clinical laboratories for scaling up COVID-19 testing with lab-developed tests must be part of a $1tn Senate coronavirus aid and relief package, clinical lab group ACLA says. Other provisions already included in the draft bill address stockpiling of testing swabs, liability protection for medtech firms, a requirement for device makers to report supply chain shortages, the expanded use of telehealth, and preventing durable medical equipment payment reductions.
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.